Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Vestnik Oftalmologii|July 22, 2010
[Possibilities of using long-wave irradiation in the near-infrared and red spectral ranges for visualization of eyeball structures]N V Pasechnikova, V A Naumenko, A R Korol', et al.Clinical Ophthalmology (Auckland, N.Z.)|November 18, 2016
Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot studyAndrii R Korol, Oleg S Zadorozhnyy, Volodymyr O Naumenko, et al.Eksperimental'Naia Onkologiia|January 1, 1984
[Effect of ceruloplasmin on the growth of experimental tumors and proliferative activity of cells]N K Berdinskikh, Iu V Voloshchenko, V I Livshits, et al.Journal of Environmental Radioactivity|December 9, 2020
Post-fire redistribution of 137Cs and algal communities in contaminated forest soils in BelarusA Dvornik, N Shamal, Y Bachura, et al.Medical Hypothesis, Discovery & Innovation Ophthalmology Journal|March 7, 2014
Serous pigment epithelium detachment associated with age-related macular degeneration: a possible treatment approachNataliya V Pasyechnikova, Volodymyr A Naumenko, Andrii R Korol, et al.Radiobiologiia|January 1, 1990
[The effect of ceruloplasmin on metabolic processes in the liver of mice during neutron exposure]S G Antonenko, N K Berdinskikh, O L Sanina, et al.Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|December 16, 2014
Intravitreal ranibizumab for the treatment of choroidal neovascularizations associated with pathologic myopia: a prospective studyNataliya V Pasyechnikova, Volodymyr O Naumenko, Andrii R Korol, et al.Clinical Ophthalmology (Auckland, N.Z.)|July 14, 2025
Treat and Extend Regimen of Aflibercept in the Treatment of Type 1 Choroidal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy: Three-year Follow-UpTaras B Kustryn, Oleg S Zadorozhnyy, Illia O Nasinnyk, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|August 10, 2022
Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function OutcomesR M Glicksman, P Cheung, R Korol, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|May 26, 2019
Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective TrialsS Roy, A Loblaw, P Cheung, et al.Pageof 3